Contrasting Yubo International Biotech (YBGJ) & Its Rivals

Insider and Institutional Ownership

44.3% of shares of all “Electromedical equipment” companies are owned by institutional investors. 56.5% of Yubo International Biotech shares are owned by insiders. Comparatively, 15.3% of shares of all “Electromedical equipment” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Yubo International Biotech and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Yubo International Biotech	-274.96%	N/A	-121.41%
Yubo International Biotech Competitors	-299.60%	-764.44%	-27.12%

Volatility and Risk

Yubo International Biotech has a beta of 2.99, meaning that its share price is 199% more volatile than the S&P 500. Comparatively, Yubo International Biotech’s competitors have a beta of 16.23, meaning that their average share price is 1,523% more volatile than the S&P 500.

Earnings & Valuation

This table compares Yubo International Biotech and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Yubo International Biotech	$610,000.00	-$1.20 million	-5.00
Yubo International Biotech Competitors	$1.02 billion	$83.13 million	9.57

Yubo International Biotech’s competitors have higher revenue and earnings than Yubo International Biotech. Yubo International Biotech is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Yubo International Biotech competitors beat Yubo International Biotech on 6 of the 9 factors compared.

Yubo International Biotech Company Profile

Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.